← back to search

Wei Tian

Harbin Medical University · CN
Area of research
Nuclear and High Energy Physics · Transportation
Research interest
Research focused on Type 2 diabetes and China, with related work in Type (biology), Cross-sectional study, Debridement (dental). Notable publications include 'Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes', 'Using primary and routinely collected data to determine prevalence and patterns of multimorbidity in rural China: a representative cross-sectional study of 6474 Chinese adults', and 'The effect of subacromial decompression on the curative effect of arthroscopic treatment of shoulder calcific tendinitis'.
h-index
—
citations
228
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Using primary and routinely collected data to determine prevalence and patterns of multimorbidity in rural China: a representative cross-sectional study of 6474 Chinese adults
The Lancet Regional Health - Western Pacific 2024cited by 5position: middledoi
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
New England Journal of Medicine 2023cited by 223position: middledoi
The effect of subacromial decompression on the curative effect of arthroscopic treatment of shoulder calcific tendinitis
Frontiers in Surgery 2023cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenzheng Li · Anhui Medical University1 papers (2023–2023)Bo Chai · Shanxi Medical University1 papers (2023–2023)Zdenĕk Šumnı́k · University Hospital in Motol1 papers (2023–2023)Kimber M. Simmons · Barbara Davis Center for Diabetes/University of Colorado School of Medicine1 papers (2023–2023)Colin Dayan · KU Leuven1 papers (2023–2023)Kevan C. Herold · Yale New Haven Hospital1 papers (2023–2023)Elisabeth Niemoeller · Sanofi (Germany)1 papers (2023–2023)Feng Zhao · China Medical University1 papers (2023–2023)Laura A. Knecht · Diabetes & Endocrine Associates1 papers (2023–2023)Lucienne Chatenoud · Inserm1 papers (2023–2023)Eleanor L. Ramos · Sanofi (United States)1 papers (2023–2023)Jianbo Wu · Shanghai Jiao Tong University1 papers (2023–2023)— · 1 papers (2023–2023)Stephen E. Gitelman · University of California at San Francisco1 papers (2023–2023)Dong Wang · Zhejiang Chinese Medical University1 papers (2023–2023)Yuming Zhang · Xuzhou Medical College1 papers (2023–2023)Peng Li · Shanxi Medical University1 papers (2023–2023)